awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33397403-C3FA7EE6-1C1A-43CE-AEB3-EEA61716900E
Q33397403-C3FA7EE6-1C1A-43CE-AEB3-EEA61716900E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33397403-C3FA7EE6-1C1A-43CE-AEB3-EEA61716900E
Phase II study of weekly docetaxel and fixed dose rate gemcitabine in patients with previously treated advanced soft tissue and bone sarcoma.
P2860
Q33397403-C3FA7EE6-1C1A-43CE-AEB3-EEA61716900E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33397403-C3FA7EE6-1C1A-43CE-AEB3-EEA61716900E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0b4bc70646affd4cc74a78406c6fb348762b0717
P2860
Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small-cell lung cancer: a Spanish Lung Cancer Group trial.